Klebsiella pneumoniae subsp. pneumoniae (Schroeter) Trevisan 菌株拉丁名
(ATCC? 43816?) 菌株編號
Application 用途 Control of experimental infections Respiratory research
Biosafety Level 生物安全等級 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Antigenic Properties Serotype 2
Product Format 提供形式 freeze-dried
Storage Conditions 保藏方法
Frozen 冷凍物 : -80°C or colder
Freeze-Dried 凍干物 : 2°C to 8°C
Live Culture 活菌 : See Propagation Section
Preceptrol? no
Type Strain 模式菌株 no
Antigenic Properties Serotype 2
Medium 培養(yǎng)基 ATCC? Medium 3: Nutrient agar or nutrient broth
Growth Conditions 生長條件
Temperature 培養(yǎng)溫度 : 37°C
Atmosphere 需氧情況 : Aerobic
Name of Depositor 寄存人 IA Woudenberg-Bakker
Chain of Custody 來源國家 ATCC <-- IA Woudenberg-Bakker <-- WA Craig <-- KR Comber
References 參考文獻 Bakker-Woudenberg IA, et al. Relevance of serum protein binding of cefoxitin and cefazolin to their activities against Klebsiella pneumoniae pneumonia in rats. Antimicrob. Agents Chemother. 28: 654-659, 1985. PubMed: 3911879
Roosendaal R, et al. Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats. J. Infect. Dis. 152: 373-378, 1985. PubMed: 3897395
Roosendaal R, et al. Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats. Antimicrob. Agents Chemother. 31: 1809-1815, 1987. PubMed: 3324962
ATCC43816
